According to Revolution Medicines
's latest financial reports the company has โฌ1.82 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | โฌ2.19 B | 31.25% |
2023-12-31 | โฌ1.67 B | 178.78% |
2022-12-31 | โฌ0.60 B | 18% |
2021-12-31 | โฌ0.50 B | 42.2% |
2020-12-31 | โฌ0.35 B | 226.99% |
2019-12-31 | โฌ0.10 B | 80.15% |
2018-12-31 | โฌ60.82 M | 703.87% |
2017-12-31 | โฌ7.56 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | โฌ0.17 B | -90.31% | ๐บ๐ธ USA |